Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Surgalign Holdings Inc SRGAQ

Healthcare Medical Instruments & Supplies
Surgalign Holdings, Inc. is a medical technology company. The Company is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology... see more

Recent & Breaking News (PINL:SRGAQ)

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire December 3, 2021

Surgalign Holdings, Inc. to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference

GlobeNewswire November 22, 2021

Surgalign Holdings, Inc. Announces Third Quarter 2021 Results

GlobeNewswire November 9, 2021

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire November 4, 2021

Surgalign Holdings, Inc. Schedules Third Quarter 2021 Earnings Release for November 9, 2021

GlobeNewswire November 3, 2021

Anika Appoints Sheryl Conley to Board of Directors

GlobeNewswire November 1, 2021

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire October 5, 2021

Surgalign Holdings Announces Management Changes

GlobeNewswire September 23, 2021

Surgalign Appoints Sheryl Conley as Chair of the Board of Directors

GlobeNewswire September 15, 2021

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire September 7, 2021

Surgalign Announces Issuance of U.S. Patent Covering the Use of Artificial Intelligence in Medical Image Segmentation

GlobeNewswire August 19, 2021

Surgalign Holdings, Inc. Announces Second Quarter 2021 Results

GlobeNewswire August 6, 2021

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire August 4, 2021

Surgalign Holdings, Inc. Schedules Second Quarter 2021 Earnings Release for August 6, 2021

GlobeNewswire July 23, 2021

Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire July 6, 2021

Sidoti Summer Virtual Small-Cap Conference

Accesswire June 22, 2021

Surgalign Holdings, Inc. to Present at the Sidoti Virtual Investor Conference

GlobeNewswire June 16, 2021

Surgalign Holdings, Inc. Announces Closing of $50 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire June 14, 2021

Surgalign Holdings, Inc. Announces $50 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire June 10, 2021

Surgalign Holdings Announces Collaboration with Inteneural Networks, a Leading Developer of Artificial Intelligence for Clinical Neurosciences

GlobeNewswire June 7, 2021